Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06486454
What this trial is testing

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Who this might be right for
Liver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2 more
HistoSonics, Inc. 5,000
Testing effectiveness (Phase 2)Ended earlyNCT01545141
What this trial is testing

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT02860546
What this trial is testing

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

Who this might be right for
Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT00020761
What this trial is testing

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 51
Not applicableStudy completedNCT00897754
What this trial is testing

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 200
Large-scale testing (Phase 3)Study completedNCT00063141
What this trial is testing

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 1,302
Not applicableStudy completedNCT01858805
What this trial is testing

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

Who this might be right for
Resectable Esophageal Cancer
Universitätsklinikum Hamburg-Eppendorf 123
Testing effectiveness (Phase 2)Ended earlyNCT00276861
What this trial is testing

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer

Who this might be right for
Colorectal Cancer
University of Miami 10
Testing effectiveness (Phase 2)Temporarily pausedNCT05200442
What this trial is testing

VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal AdenocarcinomaColorectal Cancer Metastatic+2 more
University of Chicago 53
Large-scale testing (Phase 3)UnknownNCT05002686
What this trial is testing

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

Who this might be right for
Gastric Cancer
Ruijin Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00401570
What this trial is testing

Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
AbbVie (prior sponsor, Abbott) 40
Large-scale testing (Phase 3)Study completedNCT00389870
What this trial is testing

Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil

Who this might be right for
Colorectal Cancer
University of Leeds 1,198
Early research (Phase 1)Study completedNCT02179970
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

Who this might be right for
Pancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic
CCTU- Cancer Theme 26
Testing effectiveness (Phase 2)Study completedNCT01386242
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 108
Testing effectiveness (Phase 2)Study completedNCT00752570
What this trial is testing

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

Who this might be right for
CancerCarcinomaColon Cancer+7 more
Amgen 144
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT02028442
What this trial is testing

Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients

Who this might be right for
Solid Tumours of Epithelial OriginMetastatic Colorectal CancerMetastatic Bladder Cancer
Akamis Bio 61
Testing effectiveness (Phase 2)Study completedNCT00673673
What this trial is testing

FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

Who this might be right for
Gastroesophageal CancerGastric Cancer
Yale University 39
Not applicableNot Yet RecruitingNCT06655142
What this trial is testing

OSCAR II STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC)
ExThera Medical Corporation 120
Testing effectiveness (Phase 2)Looking for participantsNCT06563986
What this trial is testing

FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
UMC Utrecht 40
Next Page